Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|June 19, 2024
Systemic Inflammation in Oncologic Patients Undergoing Systemic Treatment and Receiving Whey Protein-Based Nutritional SupportAura D Herrera-Martínez, Ana Navas Romo, Soraya León-Idougourram, et al.
NPJ Parkinson'S Disease|July 3, 2025
Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohortRuwani S Wijeyekoon, Marta Camacho, David Bäckström, et al.
Journal of Parkinson'S Disease|April 30, 2025
Dementia risk prediction in early Parkinson's disease: Validation and genetic integration of the Montreal Parkinson risk of dementia scale (MoPaRDS)Aleksandra A Szwedo, Ingvild Dalen, Rachael A Lawson, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 26, 2025
Endothelial damage and complement dysregulation in fetuses from pregnancies complicated by preeclampsiaAlex Ramos, Lina Youssef, Patricia Molina, et al.
Bioinformatics (Oxford, England)|May 27, 2010
GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge BaseGeorge Khelashvili, Kevin Dorff, Jufang Shan, et al.
Frontiers in Endocrinology|October 23, 2023
Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatmentAura D Herrera-Martínez, Laura L S Castillo-Peinado, María J Molina-Puerta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2022
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based StudyAleksandra A Szwedo, Ingvild Dalen, Kenn Freddy Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2018
Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic TherapiesRodrigo A Toledo, Elena Garralda, Maria Mitsi, et al.
Pageof 11